Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Synucleins are involved in multiple steps of the neurotransmitter turnover, but the largely normal synaptic function in young adult animals completely lacking synucleins suggests their roles are dispensable for execution of these processes. Instead, they may be utilized for boosting the efficiency of certain molecular mechanisms in presynaptic terminals, with a deficiency of synuclein proteins sensitizing to or exacerbating synaptic malfunction caused by accumulation of mild alterations, which are commonly associated with aging. Although functional redundancy within the family has been reported, it is unclear whether the remaining synucleins can fully compensate for the deficiency of a lost family member or whether some functions are specific for a particular member. We assessed several structural and functional characteristics of the nigrostriatal system of mice lacking members of the synuclein family in every possible combination and demonstrated that stabilization of the striatal dopamine level depends on the presence of α-synuclein and cannot be compensated by other family members, whereas β-synuclein is required for efficient maintenance of animal's balance and coordination in old age.

Original publication

DOI

10.1016/j.neurobiolaging.2016.06.020

Type

Journal article

Journal

Neurobiol Aging

Publication Date

10/2016

Volume

46

Pages

107 - 112

Keywords

Dopamine, Knockout mice, Nigrostriatal system, Null mutant, Parkinson's disease, Synuclein, Aging, Animals, Behavior, Animal, Dopamine, Male, Mice, Knockout, Mice, Mutant Strains, Motor Activity, Neurotransmitter Agents, Parkinson Disease, Postural Balance, Substantia Nigra, Synapses, Synucleins